Chief Executive Stephane Bancel says Moderna will work with the Trump administration. Moderna stock rose in midday trades.
Moderna, Inc. (MRNA) shares were up over 3% in choppy trading on Friday afternoon, even as the biotech firm reported a ...
The biotech giant reported a bigger-than-expected quarterly loss. Finance chief James Mock attributed the loss to a scale down.